| Kastytis Leonas Buitkus, MD | |
|
21700 Greenfield Rd, Suite 130, Oak Park, MI 48237-2581 | |
| (248) 967-4310 | |
| (248) 967-4301 |
| Full Name | Kastytis Leonas Buitkus |
|---|---|
| Gender | Male |
| Speciality | Allergy & Immunology - Allergy |
| Location | 21700 Greenfield Rd, Oak Park, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881638625 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | KB050601 (Michigan) | Primary |
| 207RA0401X | Internal Medicine - Addiction Medicine | KB050601 (Michigan) | Secondary |
| Entity Name | Lawrence M Dell, Md, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497766406 PECOS PAC ID: 1456398775 Enrollment ID: O20050408000348 |
News Archive
As part of a new long-term alliance, Stand Up To Cancer is gearing up for its next Team Fundraising Challenge by joining forces with one of television's most popular shows, Survivor on CBS. For the first time ever, Survivor will stand up and issue the "Challenge The Odds" Team Challenge with Stand Up To Cancer Ambassador and winner of Survivor: Africa, Ethan Zohn.
What many Americans eat and how little they exercise could wind up costing them - and American taxpayers - some serious money. Moreover, the overweight and obese may lose months from their lifespans.
Genentech, Inc. and Roche have announced that the New England Journal of Medicine published the first Phase III study of an anti-angiogenesis cancer therapy, showing that the addition of Avastin™ (bevacizumab) to the IFL chemotherapy regimen (5-FU/Leucovorin/ CPT-11) significantly extended survival in patients with first-line (previously untreated) metastatic colorectal cancer.
The simultaneous stimulation of the motor nerves of the brain and limbs (paired associative stimulation) has yielded promising research results.
Will the high costs of treating cancer bankrupt the world's economies? A new report says more people are getting cancer than ever before. And while cancer-care may be more advanced than ever, it's also more expensive -; and that suggests some countries may not be unable to afford it.
› Verified 3 days ago
| Entity Name | Metropolitan Rehabilitation Clinics, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811020035 PECOS PAC ID: 8022039742 Enrollment ID: O20051209000233 |
News Archive
As part of a new long-term alliance, Stand Up To Cancer is gearing up for its next Team Fundraising Challenge by joining forces with one of television's most popular shows, Survivor on CBS. For the first time ever, Survivor will stand up and issue the "Challenge The Odds" Team Challenge with Stand Up To Cancer Ambassador and winner of Survivor: Africa, Ethan Zohn.
What many Americans eat and how little they exercise could wind up costing them - and American taxpayers - some serious money. Moreover, the overweight and obese may lose months from their lifespans.
Genentech, Inc. and Roche have announced that the New England Journal of Medicine published the first Phase III study of an anti-angiogenesis cancer therapy, showing that the addition of Avastin™ (bevacizumab) to the IFL chemotherapy regimen (5-FU/Leucovorin/ CPT-11) significantly extended survival in patients with first-line (previously untreated) metastatic colorectal cancer.
The simultaneous stimulation of the motor nerves of the brain and limbs (paired associative stimulation) has yielded promising research results.
Will the high costs of treating cancer bankrupt the world's economies? A new report says more people are getting cancer than ever before. And while cancer-care may be more advanced than ever, it's also more expensive -; and that suggests some countries may not be unable to afford it.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kastytis Leonas Buitkus, MD 6593 Minnow Pond Dr, West Bloomfield, MI 48322-2660 Ph: (248) 926-4047 | Kastytis Leonas Buitkus, MD 21700 Greenfield Rd, Suite 130, Oak Park, MI 48237-2581 Ph: (248) 967-4310 |
News Archive
As part of a new long-term alliance, Stand Up To Cancer is gearing up for its next Team Fundraising Challenge by joining forces with one of television's most popular shows, Survivor on CBS. For the first time ever, Survivor will stand up and issue the "Challenge The Odds" Team Challenge with Stand Up To Cancer Ambassador and winner of Survivor: Africa, Ethan Zohn.
What many Americans eat and how little they exercise could wind up costing them - and American taxpayers - some serious money. Moreover, the overweight and obese may lose months from their lifespans.
Genentech, Inc. and Roche have announced that the New England Journal of Medicine published the first Phase III study of an anti-angiogenesis cancer therapy, showing that the addition of Avastin™ (bevacizumab) to the IFL chemotherapy regimen (5-FU/Leucovorin/ CPT-11) significantly extended survival in patients with first-line (previously untreated) metastatic colorectal cancer.
The simultaneous stimulation of the motor nerves of the brain and limbs (paired associative stimulation) has yielded promising research results.
Will the high costs of treating cancer bankrupt the world's economies? A new report says more people are getting cancer than ever before. And while cancer-care may be more advanced than ever, it's also more expensive -; and that suggests some countries may not be unable to afford it.
› Verified 3 days ago
Dr. Michael L. Steinberg, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 14631 Balfour St, Oak Park, MI 48237 Phone: 412-841-5983 |